HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,117,656 | +5.9% | 29,258 | -0.0% | 0.03% | +10.7% |
| Q2 2023 | $1,055,552 | -7.9% | 29,264 | -2.4% | 0.03% | -6.7% |
| Q1 2023 | $1,145,624 | +60.9% | 29,998 | +139.7% | 0.03% | +57.9% |
| Q4 2022 | $711,990 | -9.5% | 12,513 | -37.1% | 0.02% | -5.0% |
| Q3 2022 | $787,000 | -22.5% | 19,899 | -13.8% | 0.02% | -16.7% |
| Q2 2022 | $1,016,000 | +8.9% | 23,091 | -1.2% | 0.02% | +14.3% |
| Q1 2022 | $933,000 | -0.5% | 23,383 | +0.2% | 0.02% | +16.7% |
| Q4 2021 | $938,000 | -1.9% | 23,339 | -0.7% | 0.02% | -10.0% |
| Q3 2021 | $956,000 | -5.5% | 23,512 | +5.5% | 0.02% | +11.1% |
| Q2 2021 | $1,012,000 | +14.5% | 22,290 | +5.1% | 0.02% | +12.5% |
| Q1 2021 | $884,000 | -52.6% | 21,211 | -51.5% | 0.02% | -36.0% |
| Q4 2020 | $1,866,000 | – | 43,691 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |